Sykes et al. (14) had previously shown that the pharmacological DHODH inhibition leads to reduced AML LSCs survival and the inhibitor can induce their terminal differentiation, indicating that DHODH is a potential differentiation regulator. The gene discussed is DHODH; the disease is acute myeloid leukemia.